Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 5017 to 5021 of 5021 entries
Sorted by: Best Match Show Resources per page
Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension.

Life (Basel, Switzerland)

Yang Q, Hori M.
PMID: 34357074
Life (Basel). 2021 Jul 16;11(7). doi: 10.3390/life11070702.

Hypertension is a key risk factor for cardiovascular disease and it is a growing public health problem worldwide. The pathophysiological mechanisms of vascular smooth muscle (VSM) contraction contribute to the development of hypertension. Calcium (Ca

Cite
Yang Q, Hori M. Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension. Life (Basel). 2021;11(7)doi: 10.3390/life11070702.
Yang, Q., & Hori, M. (2021). Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension. Life (Basel, Switzerland), 11(7), . https://doi.org/10.3390/life11070702
Yang, Qunhui, and Hori, Masatoshi. "Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension." Life (Basel, Switzerland) vol. 11,7 (2021). doi: https://doi.org/10.3390/life11070702
Yang Q, Hori M. Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension. Life (Basel). 2021 Jul 16;11(7). doi: 10.3390/life11070702. PMID: 34357074; PMCID: PMC8304034.
Copy Download .nbib Format: NLM
Risk factors for intraoperative complications in pheochromocytomas.

Endocrine-related cancer

Araujo-Castro M, Garcia Centeno R, López-García MC, Lamas C, Álvarez-Escolá C, Calatayud Gutiérrez M, Blanco-Carrera C, de Miguel Novoa P, Valdés N, Gracia Gimeno P, Fernández-Ladreda MT, Mínguez Ojeda C, Percovich Hualpa JC, Mora M, Vidal Ó, Serrano Romero A, Hanzu FA, Gómez Dos Santos V.
PMID: 34379605
Endocr Relat Cancer. 2021 Sep 08;28(11):695-703. doi: 10.1530/ERC-21-0230.

We aimed to identify presurgical and surgical risk factors for intraoperative complications in patients with pheochromocytomas. A retrospective study of patients with pheochromocytomas who underwent surgery in ten Spanish hospitals between 2011 and 2021 was performed. One hundred and...

Cite
Araujo-Castro M, Garcia Centeno R, López-García MC, et al. Risk factors for intraoperative complications in pheochromocytomas. Endocr Relat Cancer. 2021;28(11):695-703doi: 10.1530/ERC-21-0230.
Araujo-Castro, M., Garcia Centeno, R., López-García, M. C., Lamas, C., Álvarez-Escolá, C., Calatayud Gutiérrez, M., Blanco-Carrera, C., de Miguel Novoa, P., Valdés, N., Gracia Gimeno, P., Fernández-Ladreda, M. T., Mínguez Ojeda, C., Percovich Hualpa, J. C., Mora, M., Vidal, �. �., Serrano Romero, A., Hanzu, F. A., & Gómez Dos Santos, V. (2021). Risk factors for intraoperative complications in pheochromocytomas. Endocrine-related cancer, 28(11), 695-703. https://doi.org/10.1530/ERC-21-0230
Araujo-Castro, Marta, et al. "Risk factors for intraoperative complications in pheochromocytomas." Endocrine-related cancer vol. 28,11 (2021): 695-703. doi: https://doi.org/10.1530/ERC-21-0230
Araujo-Castro M, Garcia Centeno R, López-García MC, Lamas C, Álvarez-Escolá C, Calatayud Gutiérrez M, Blanco-Carrera C, de Miguel Novoa P, Valdés N, Gracia Gimeno P, Fernández-Ladreda MT, Mínguez Ojeda C, Percovich Hualpa JC, Mora M, Vidal Ó, Serrano Romero A, Hanzu FA, Gómez Dos Santos V. Risk factors for intraoperative complications in pheochromocytomas. Endocr Relat Cancer. 2021 Sep 08;28(11):695-703. doi: 10.1530/ERC-21-0230. PMID: 34379605.
Copy Download .nbib Format: NLM
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis.

Molecules (Basel, Switzerland)

Mori M, Villa S, Ciceri S, Colombo D, Ferraboschi P, Meneghetti F.
PMID: 34885662
Molecules. 2021 Nov 23;26(23). doi: 10.3390/molecules26237082.

The elucidation of the structure of enzymes and their complexes with ligands continues to provide invaluable insights for the development of drugs against many diseases, including bacterial infections. After nearly three decades since the World Health Organization's (WHO) declaration...

Cite
Mori M, Villa S, Ciceri S, et al. An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis. Molecules. 2021;26(23)doi: 10.3390/molecules26237082.
Mori, M., Villa, S., Ciceri, S., Colombo, D., Ferraboschi, P., & Meneghetti, F. (2021). An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237082
Mori, Matteo, et al. "An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237082
Mori M, Villa S, Ciceri S, Colombo D, Ferraboschi P, Meneghetti F. An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis. Molecules. 2021 Nov 23;26(23). doi: 10.3390/molecules26237082. PMID: 34885662; PMCID: PMC8659263.
Copy Download .nbib Format: NLM
Risk Assessment of Passive Smoking Based on Analysis of Hair Nicotine and Cotinine as Exposure Biomarkers by In-Tube Solid-Phase Microextraction Coupled On-Line to LC-MS/MS.

Molecules (Basel, Switzerland)

Kataoka H, Kaji S, Moai M.
PMID: 34885941
Molecules. 2021 Dec 03;26(23). doi: 10.3390/molecules26237356.

Passive smoking due to environmental tobacco smoke is a serious public health concern because it increases the risk of lung cancer and cardiovascular disease. However, the current status and effect of passive smoking in various lifestyles are not fully...

Cite
Kataoka H, Kaji S, Moai M. Risk Assessment of Passive Smoking Based on Analysis of Hair Nicotine and Cotinine as Exposure Biomarkers by In-Tube Solid-Phase Microextraction Coupled On-Line to LC-MS/MS. Molecules. 2021;26(23)doi: 10.3390/molecules26237356.
Kataoka, H., Kaji, S., & Moai, M. (2021). Risk Assessment of Passive Smoking Based on Analysis of Hair Nicotine and Cotinine as Exposure Biomarkers by In-Tube Solid-Phase Microextraction Coupled On-Line to LC-MS/MS. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237356
Kataoka, Hiroyuki, et al. "Risk Assessment of Passive Smoking Based on Analysis of Hair Nicotine and Cotinine as Exposure Biomarkers by In-Tube Solid-Phase Microextraction Coupled On-Line to LC-MS/MS." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237356
Kataoka H, Kaji S, Moai M. Risk Assessment of Passive Smoking Based on Analysis of Hair Nicotine and Cotinine as Exposure Biomarkers by In-Tube Solid-Phase Microextraction Coupled On-Line to LC-MS/MS. Molecules. 2021 Dec 03;26(23). doi: 10.3390/molecules26237356. PMID: 34885941; PMCID: PMC8659248.
Copy Download .nbib Format: NLM
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.

Investigational new drugs

Omori S, Harada H, Mori K, Hisamatsu Y, Tsuboguchi Y, Yoshioka H, Morinaga R, Daga H, Kurata T, Takahashi T.
PMID: 34495421
Invest New Drugs. 2022 Feb;40(1):106-114. doi: 10.1007/s10637-021-01155-w. Epub 2021 Sep 08.

Few clinical studies have been designed for elderly patients with locally advanced non-small cell lung cancer (NSCLC). We conducted a phase I study to evaluate the tolerability of carboplatin/nab-paclitaxel and concurrent thoracic radiotherapy in elderly patients with locally advanced...

Cite
Omori S, Harada H, Mori K, et al. Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer. Invest New Drugs. 2021;40(1):106-114doi: 10.1007/s10637-021-01155-w.
Omori, S., Harada, H., Mori, K., Hisamatsu, Y., Tsuboguchi, Y., Yoshioka, H., Morinaga, R., Daga, H., Kurata, T., & Takahashi, T. (2022). Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer. Investigational new drugs, 40(1), 106-114. https://doi.org/10.1007/s10637-021-01155-w
Omori, Shota, et al. "Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer." Investigational new drugs vol. 40,1 (2022): 106-114. doi: https://doi.org/10.1007/s10637-021-01155-w
Omori S, Harada H, Mori K, Hisamatsu Y, Tsuboguchi Y, Yoshioka H, Morinaga R, Daga H, Kurata T, Takahashi T. Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer. Invest New Drugs. 2022 Feb;40(1):106-114. doi: 10.1007/s10637-021-01155-w. Epub 2021 Sep 08. PMID: 34495421.
Copy Download .nbib Format: NLM
Showing 5017 to 5021 of 5021 entries